New research indicates proportion of young women who have never been screened for cervical cancer more than doubled since 2005
Developed by a British firm, the test will be available as a $29 add-on to pricier genetic profiling assays
Clinical laboratories may soon be able to use a simplified LDL cholesterol calculation
...
From – Diagnostic Testing & Emerging Technologies
More than 28 percent of the novel new drugs approved by U.S. Food and Drug Administration (FDA) in 2015 were…
From – Diagnostic Testing & Emerging Technologies
Prostate specific antigen (PSA) testing varies significantly by physician specialty, according to a research letter published online Feb. 8 in…
...
...
From – Diagnostic Testing & Emerging Technologies
Simple, brief, information sheets are unlikely to change patients’ intentions to participate in low-value screenings, according to a study published online…
...